Company intelligence / Profile preview

Diabeta

Bucharest, Romania

Ownership: Private
Development stage: Other

Overview

DiaBeta is a digital health company that provides an AI-powered platform designed to optimize the management of diabetes for both patients and healthcare professionals. The platform utilizes advanced machine learning algorithms to analyze patient data, including glycemic levels and lifestyle factors, to provide personalized clinical decision support and treatment recommendations. By integrating with electronic health records and wearable devices, DiaBeta aims to improve glycemic control and streamline the clinical workflow for diabetes care. The company's technology focuses on enhancing the precision of insulin dosing and lifestyle interventions through data-driven insights.

Therapeutic areas: Endocrinology
Modalities: SoftwareAI
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Diabeta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diabeta.

Explore the full profile